Education for Low Oxygen Levels

Overseen By Carrie Higgins, BSN

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Colorado, Denver

Disqualifiers: Transferred patients, Chronic ventilation, Pregnancy, Prisoners

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: Duration of ICU stay

3600 Participants Needed

Trial Summary

What is the purpose of this trial?

A multimodal educational intervention to target an oxygen saturation target range (SpO2 90-96%) will reduce ventilator length of stay and reduce occult hypoxemia by increased awareness and adherence to a designated oxygen saturation target range.

Research Team

Neil Aggarwal, MD

Principal Investigator

University of Colorado, Denver

Eligibility Criteria

This trial is for patients in the ICU who need machines to help them breathe. They're looking at whether educating healthcare staff about oxygen levels can help these patients.

Inclusion Criteria

I am in the ICU and on a breathing machine.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2 weeks

Educational Intervention

Standardized education and materials are provided to local stakeholders for hospital and ICU-level implementation, including virtual respiratory therapist-directed real-time feedback on adherence to the SpO2 target range.

2 weeks

Virtual sessions

Treatment

Implementation of the targeted oxygen saturation (SpO2) range of 90-96% in adult patients receiving mechanical ventilation using a multimodal educational intervention strategy.

Duration of ICU stay

Follow-up

Participants are monitored for safety and effectiveness after treatment, including tracking ICU free days, hospital free days, and ventilator free days.

90 days

Treatment Details

Interventions

• Multimodal Educational Intervention

Trial Overview The study tests if training ICU teams to keep patient's oxygen saturation between 90-96% can shorten the time on ventilators and prevent low oxygen levels without being noticed.

Participant Groups

Group I: Educational intervention Experimental Treatment 1 Intervention

SP02 target ranges will be 90-96%. Education about the specific oxygen targets will be provided to the clinical teams. Real time feedback on adherence to the Sp02 target range will be provided by virtual respiratory therapists.

Who Is Running the Clinical Trial?

University of Colorado, Denver

Lead Sponsor

Trials

1,842

Recruited

3,028,000+